Carmen Cantisani Selected Research

Carmen Cantisani Research Topics

Disease

5	Actinic Keratosis 06/2022 - 01/2016
4	Basal Cell Carcinoma (Rodent Ulcer) 01/2020 - 03/2011
3	Neoplasms (Cancer) 08/2022 - 02/2018
3	Hypersensitivity (Allergy) 06/2022 - 01/2010
3	Melanoma (Melanoma, Malignant) 02/2019 - 01/2015
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 07/2011
2	COVID-19 06/2022 - 01/2021
2	Skin Neoplasms (Skin Cancer) 01/2019 - 02/2018
2	Pain (Aches) 07/2016 - 01/2014
2	Localized Scleroderma (Morphea) 01/2013 - 05/2010
1	Melanosis (Freckles) 03/2024
1	Kaposi Sarcoma (Kaposi's Sarcoma) 09/2023
1	Inflammation (Inflammations) 03/2023
1	Ulcerative Colitis 03/2023
1	Atopic Dermatitis (Atopic Eczema) 03/2023
1	Carcinoma (Carcinomatosis) 08/2022
1	Hypertrophy 07/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Pityriasis Rosea 01/2021
1	Prodromal Symptoms 01/2021
1	Infections 01/2021
1	Granuloma 01/2020
1	Actinic cheilitis 01/2020
1	Lentigo (Lentiginosis) 01/2020
1	Carcinogenesis 02/2019
1	Acne Vulgaris 02/2019
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 02/2019
1	Psoriatic Arthritis 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hemorrhage 01/2019
1	Crohn Disease (Crohn's Disease) 01/2019
1	Skin Manifestations 01/2019
1	Glaucoma 01/2014
1	Amnesia (Dissociative Amnesia) 01/2014
1	Vitiligo 04/2013
1	Hypertension (High Blood Pressure) 05/2012
1	Alopecia (Baldness) 05/2012
1	Allergic Contact Dermatitis 05/2012
1	Photoallergic Dermatitis (Photoallergy) 01/2010
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2010
1	Acute Generalized Exanthematous Pustulosis 04/2005

Drug/Important Bio-Agent (IBA)

6	Imiquimod (Aldara)FDA LinkGeneric 09/2023 - 03/2011
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2022 - 07/2016
2	SteroidsIBA 01/2021 - 01/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 11/2013
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2010
1	upadacitinibIBA 03/2023
1	CytokinesIBA 03/2023
1	Janus Kinase InhibitorsIBA 03/2023
1	Fluorouracil (Carac)FDA LinkGeneric 08/2022
1	RetinoidsIBA 08/2022
1	Polysaccharides (Glycans)IBA 07/2022
1	VaccinesIBA 06/2022
1	AcidsIBA 06/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Histamine Antagonists (Antihistamines)IBA 01/2021
1	Dapsone FDA Link 01/2020
1	Tryptases (Tryptase)IBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 02/2019
1	Isotretinoin (Accutane)FDA LinkGeneric 02/2019
1	Chymases (Chymase)IBA 02/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	Etanercept (Enbrel)FDA Link 01/2019
1	GlucocorticoidsIBA 01/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	Triamcinolone (Aristocort)FDA Link 01/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Diclofenac (SR 38)FDA LinkGeneric 11/2018
1	Hyaluronic Acid (Hyaluronan)IBA 11/2018
1	Vitamin D FDA LinkGeneric 01/2015
1	3-ingenyl angelateIBA 11/2014
1	Anesthetics (Anesthetic Agents)IBA 01/2014
1	Local AnestheticsIBA 01/2014
1	Ophthalmic Solutions (Eye Drops)IBA 01/2014
1	AutoantigensIBA 04/2013
1	Ointments (Pastes)IBA 01/2013
1	SolutionsIBA 05/2012
1	Vasodilator Agents (Vasodilators)IBA 05/2012
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 05/2012
1	Minoxidil (Rogaine)FDA LinkGeneric 05/2012
1	Irritants (Vesicants)IBA 05/2012
1	altersolanol AIBA 05/2012
1	HomocysteineIBA 07/2011
1	Ketoprofen (Orudis)FDA LinkGeneric 01/2010
1	Sunscreening Agents (Sunscreens)IBA 01/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010

Therapy/Procedure

6	Therapeutics 03/2023 - 11/2013
6	Photochemotherapy (Photodynamic Therapy) 08/2022 - 07/2016
2	Lasers (Laser) 03/2024 - 08/2022
2	Aftercare (After-Treatment) 09/2023 - 01/2019
1	Cryotherapy (Therapy, Cold) 08/2022
1	Precision Medicine 01/2022
1	Electrodes (Electrode) 02/2018
1	Analgesia 01/2014
1	General Anesthesia 01/2014